Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Oxidative Stress And Heart Failure.
H. Tsutsui, S. Kinugawa, S. Matsushima
Published 2011 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Oxidative stress, defined as an excess production of reactive oxygen species (ROS) relative to antioxidant defense, has been shown to play an important role in the pathophysiology of cardiac remodeling and heart failure (HF). It induces subtle changes in intracellular pathways, redox signaling, at lower levels, but causes cellular dysfunction and damage at higher levels. ROS are derived from several intracellular sources, including mitochondria, NAD(P)H oxidase, xanthine oxidase, and uncoupled nitric oxide synthase. The production of ROS is increased within the mitochondria from failing hearts, whereas normal antioxidant enzyme activities are preserved. Chronic increases in ROS production in the mitochondria lead to a catastrophic cycle of mitochondrial DNA (mtDNA) damage as well as functional decline, further ROS generation, and cellular injury. ROS directly impair contractile function by modifying proteins central to excitation-contraction coupling. Moreover, ROS activate a broad variety of hypertrophy signaling kinases and transcription factors and mediate apoptosis. They also stimulate cardiac fibroblast proliferation and activate the matrix metalloproteinases, leading to the extracellular matrix remodeling. These cellular events are involved in the development and progression of maladaptive myocardial remodeling and failure. Oxidative stress is also involved in the skeletal muscle dysfunction, which may be associated with exercise intolerance and insulin resistance in HF. Therefore, oxidative stress is involved in the pathophysiology of HF in the heart as well as in the skeletal muscle. A better understanding of these mechanisms may enable the development of novel and effective therapeutic strategies against HF.
This paper references
Insulin resistance and risk of congestive heart failure.
E. Ingelsson (2005)
Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure.
S. Hamaguchi (2010)
Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury.
H. Tsutsui (2001)
Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart.
S. Matsushima (2006)
Nitric oxide and peroxynitrite in health and disease.
P. Pacher (2007)
Characteristics and outcomes of patients with heart failure in general practices and hospitals.
H. Tsutsui (2007)
Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan.
S. Hamaguchi (2010)
Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats.
T. Abe (2002)
Overexpression of Mitochondrial Transcription Factor A Ameliorates Mitochondrial Deficiencies and Cardiac Failure After Myocardial Infarction
M. Ikeuchi (2005)
Increased myocardial NADPH oxidase activity in human heart failure.
C. Heymes (2003)
Mitochondrial Transcription Factor A in the Maintenance of Mitochondrial DNA
D. Kang (2005)
The biogenesis of mitochondria.
Gottfried Schatz (1970)
Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated Cardiomyopathy
Khalid M. Minhas (2006)
Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial
R. Marchioli (2006)
The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy.
L. Nikolaidis (2004)
8-Oxo-dGTPase, Which Prevents Oxidative Stress-Induced DNA Damage, Increases in the Mitochondria From Failing Hearts
H. Tsutsui (2001)
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging.
H. Van Remmen (2003)
Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction.
C. Wu (2009)
Mitochondrial DNA maintenance in vertebrates.
G. Shadel (1997)
A Defect of Neuronal Nitric Oxide Synthase Increases Xanthine Oxidase–Derived Superoxide Anion and Attenuates the Control of Myocardial Oxygen Consumption by Nitric Oxide Derived From Endothelial Nitric Oxide Synthase
S. Kinugawa (2005)
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats.
M. Hill (1996)
Vascular Endothelial Dysfunction and Mortality Risk in Patients With Chronic Heart Failure
S. Katz (2005)
PE-500 Genetic Risk for Lone Atrial Fibrillation(Genetics/Genetically engineered models/Gene therapy-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Kimihiko Katoh (2007)
Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction.
T. Shiomi (2003)
Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats.
G. Norton (1996)
Mitochondrial oxidative stress in heart failure: "oxygen wastage" revisited.
D. Sawyer (2000)
Lipid peroxidation and activity of antioxidant enzymes in diabetic rats
R. Kakkar (2005)
H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways.
S. H. Kwon (2003)
Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model.
K. Mizushige (2000)
Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
C. T. Lê (1993)
Oxidant signals and oxidative stress.
T. Finkel (2003)
The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.
H. Cingolani (2006)
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
S. Haffner (1998)
Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival.
Miyuki Tsuchihashi-Makaya (2010)
Critical Role of the NAD(P)H Oxidase Subunit p47phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction
C. Doerries (2007)
Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes.
S. Matsushima (2009)
Diabetes and Cardiovascular Disease: The Framingham Study
W. Kannel (1979)
Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
H. Ruetten (2005)
Hyperuricemia predicts adverse outcomes in patients with heart failure.
S. Hamaguchi (2011)
Insulin resistance and hypertension.
J. Sowers (1990)
Fatty acids increase the circulating levels of oxidative stress factors in mice with diet‐induced obesity via redox changes of albumin
Mayumi Yamato (2007)
Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event.
R. Williams (1986)
Myocyte Death in Streptozotocin-Induced Diabetes in Rats Is Angiotensin II- Dependent
F. Fiordaliso (2000)
Oxy free radical system in heart failure and therapeutic role of oral vitamin E.
A. Ghatak (1996)
Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.
G. Paolisso (1999)
Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
K. Swedberg (1988)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
M. Pfeffer (2003)
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
B. Pitt (1999)
Endothelial Nitric Oxide Synthase Limits Left Ventricular Remodeling After Myocardial Infarction in Mice
M. Scherrer‐Crosbie (2001)
Clinical characteristics and outcome of hospitalized patients with heart failure in Japan.
H. Tsutsui (2006)
Allopurinol Enhances the Contractile Response to Dobutamine and Exercise in Dogs With Pacing-Induced Heart Failure
T. Ukai (2001)
Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities
Jason J. Gajarsa (2010)
Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy
T. Cappola (2001)
Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria
S. E. Schriner (2005)
Role of oxidative stress in cardiac hypertrophy and remodeling.
E. Takimoto (2007)
Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium.
T. Ide (2000)
Biomarkers in heart failure.
E. Braunwald (2008)
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
J. Kuroda (2010)
Overexpression of Mn superoxide dismutase does not increase life span in mice.
Youngmok C. Jang (2009)
Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction
T. Ide (2001)
NOX enzymes and the biology of reactive oxygen
J. Lambeth (2004)
Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure?
E. Creemers (2001)
Treatment With Dimethylthiourea Prevents Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction in Mice: Role of Oxidative Stress
S. Kinugawa (2000)
Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart.
A. Kanazawa (2002)
Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled Studies
W. Doehner (2002)
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
J. Beckman (2002)
Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link.
R. Witteles (2004)
Overexpression of Glutathione Peroxidase Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice
T. Shiomi (2004)
Myocardial hypertrophy of normotensive Wistar-Kyoto rats.
E. Aiello (2004)
Mitochondrial Abnormalities in Tumor Necrosis Factor-&agr;–Induced Heart Failure Are Associated With Impaired DNA Repair Activity
Y. Li (2001)
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.
L. Rohde (1999)
The clinical significance of endothelial dysfunction
U. Landmesser (2005)
Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure.
H. Smith (2005)
Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure
Miyuki Tsuchihashi-Makaya (2010)
Clinical practice. Systolic heart failure.
J. McMurray (2010)
Oxidative Stress Mediates Tumor Necrosis Factor-&agr;–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac Myocytes
N. Suematsu (2003)
Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure.
W. Tang (2007)
Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure.
Z. Mallat (1998)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
B. Pitt (2000)
Chronic Kidney Disease as an Independent Risk for Long-Term Adverse Outcomes in Patients Hospitalized With Heart Failure in Japan
S. Hamaguchi (2009)
Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.
F. Spinale (1998)
Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.
S. Rajagopalan (1996)
Molecular Mechanisms of Angiotensin II–Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction
A. Doughan (2008)
Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction.
M. Hill (1997)
Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA.
C. Giulivi (1995)
Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production.
J. Bauersachs (1999)
Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium.
T. Ide (1999)
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
E. Lonn (2005)
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial
D. Aguilar (2004)
Effect of carvedilol on survival in severe chronic heart failure.
M. Packer (2001)
Reactive oxygen species and vascular biology: implications in human hypertension
R. Touyz (2011)
Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
S. Hayashidani (2003)
Replication and transcription of vertebrate mitochondrial DNA.
D. Clayton (1991)
Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells.
S. Ballinger (2000)
Oxygen free radicals and congestive heart failure.
J. Belch (1991)
Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes.
A. Sabri (2003)
Oxidative Stress–Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy
D. Cesselli (2001)
Transgenic Overexpression of Locally Acting Insulin-Like Growth Factor-1 Inhibits Ubiquitin-Mediated Muscle Atrophy in Chronic Left-Ventricular Dysfunction
P. Schulze (2005)
Insulin Signalling and Resistance in Patients with Chronic Heart Failure
J. Kemppainen (2003)
Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.
E. Takimoto (2005)
Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy
L. Nikolaidis (2004)
Redox regulation of cardiac calcium channels and transporters.
A. V. Zima (2006)
Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species.
M. Perrelli (2011)
A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure.
M. Keith (2001)
Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II
J. Li (2003)
Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice.
Y. Liao (2006)
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.
U. Landmesser (2003)
Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice
S. Matsushima (2006)
Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure.
Y. Ohta (2011)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
J. Cohn (2001)
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
B. Pitt (2000)
Upregulation of Nox4 by Hypertrophic Stimuli Promotes Apoptosis and Mitochondrial Dysfunction in Cardiac Myocytes
T. Ago (2010)
Role of oxidative stress in transition of hypertrophy to heart failure.
A. Dhalla (1996)
Oxidative stress in heart failure: what are we missing?
D. Sawyer (2011)
Effects of ACE Inhibition on Left Ventricular Failure and Oxidative Stress in Dahl Salt‐Sensitive Rats
H. Tsutsui (2001)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡
K. Dickstein (2008)
Progressive ventricular remodeling in rat with myocardial infarction.
J. Pfeffer (1991)
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
M. Rajesh (2010)
Characteristics and Outcomes of Hospitalized Patients With Heart Failure and Reduced vs Preserved Ejection Fraction
Miyuki Tsuchihashi-Makaya (2009)
This paper is referenced by
Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men
S. Schmidt (2012)
Ischaemic preconditioning in exercise and disease: One size fits all?
J. Seeger (2016)
NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress
C. Wei (2014)
Cancer Prevention by Antioxidant Compounds from Berries
N. P. Zimmerman (2013)
Thioredoxin-2 Inhibits Mitochondrial Reactive Oxygen Species Generation and Apoptosis Stress Kinase-1 Activity to Maintain Cardiac Function
Qunhua Huang (2015)
Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress.
V. Prasad (2013)
Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice
H. Lu (2016)
Inflammation in Heart Failure with Preserved Ejection Fraction
V. V. Empel (2015)
Pathogenic implications of dysregulated miRNAs in propionic acidemia related cardiomyopathy.
A. Fulgencio-Covián (2019)
Heart failure in chronic kidney disease patients: a summary approach on non-traditional risk factors
Ana Luísa Leonardo Fernandes de Viveiros (2018)
Cardiovascular susceptibility to in vivo ischemic myocardial injury in male and female rat offspring exposed to prenatal hypoxia.
Amin Shah (2017)
Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers.
F. Sanchis-Gomar (2013)
(-)-Epigallocatechin-3-gallate suppresses cigarette smoke-induced inflammation in human cardiomyocytes via ROS-mediated MAPK and NF-κB pathways.
Yingmin Liang (2019)
Impact of empagliflozin in patients with diabetes and heart failure.
D. Pham (2017)
Az oxidatív stressz szerepe szívelégtelenségben
Roland Gál (2015)
The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H2O2-induced oxidative stress in H9C2 cells.
V. Ghorbanzadeh (2020)
Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy model
Kleopatra Rapti (2017)
Acute ascorbic acid infusion increases left ventricular diastolic function in postmenopausal women.
C. Ozemek (2016)
8-Oxoguanine DNA glycosylase 1 (ogg1) maintains the function of cardiac progenitor cells during heart formation in zebrafish.
Lifeng Yan (2013)
Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts
Barbora Vitverová (2020)
NEW CHALLENGES FOR THE MANAGEMENT OF CARDIOVASCULAR AND NEUROLOGICAL DISORDERS IN THE ELDERLY Novel instruments for risk stratification of elderly patients with cardiovascular diseases Beta-blockers for the treatment of elderly patients with coexisting heart failure and chronic obstructive pulmonary
G. Corbi (2015)
Melatonin as a novel cardioprotective therapy in pulmonary hypertension
G. Maarman (2014)
Highly-sensitive troponin I is increased in patients with gynecological cancers.
E. Danese (2013)
Myofilament carbonylation modulates contractility in human cardiomyocytes
Á. Balogh (2014)
Chronic cyclic bladder over distention up-regulates hypoxia dependent pathways.
H. Stephany (2013)
IMPAIRED IMMUNE PHENOTYPE OF CIRCULATING ENDOTHELIAL- DERIVED MICROPARTICLES IN NONE-DIABETIC PATIENTS WITH CHRONIC HEART FAILURE: IMPACT ON INSULIN RESISTANCE
Alexander E. Berezin (2015)
Cardioprotective mechanisms targeting thiol redox homeostasis and mitochondrial bioenergetics
Rick J. Alleman (2016)
Prevalence of Short Stature and Growth Hormone Deficiency and Factors Associated With Short Stature After Fontan Surgery
S. Matsumura (2020)
Selenium deficiency-induced thioredoxin suppression and thioredoxin knock down disbalanced insulin responsiveness in chicken cardiomyocytes through PI3K/Akt pathway inhibition.
J. Yang (2017)
Link between cardiac function and the antioxidative defense mechanism in aged rats.
X. Qian (2019)
Thioredoxin silencing-induced cardiac supercontraction occurs through endoplasmic reticulum stress and calcium overload in chicken.
J. Yang (2018)
Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats.
P. Raj (2016)See more